Attention Deficit Hyperactivity Disorder (ADHD)
Drug Market
Attention Deficit Hyperactivity Disorder (ADHD)
Drug Market Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Attention Deficit Hyperactivity Disorder (ADHD) Drug
Market Size and Growth
The global ADHD drug market is projected to reach a value of $25.7 billion by 2025, with a CAGR of 6.5% between 2020-2025. Market growth is driven by increasing awareness and diagnosis rates of ADHD, along with the development of novel therapies and improved treatment options. Increasing research and development activities are also contributing to market expansion.
Request Sample Report
Companies Covered (Covid 19 Impact Covered)
◍ Eli Lilly
◍ Perdue Pharma
◍ Johnson & Johnson
◍ Janssen Pharmaceuticals, Inc.
◍ Shire
◍ Glaxosmith Kline
◍ Novartis
◍ Celltech Group
The ADHD drug market is highly competitive, with key players such as Eli Lilly, Perdue Pharma, Johnson & Johnson, Janssen Pharmaceuticals, Shire, Glaxosmith Kline, Novartis, and Celltech Group. These companies develop and market medications for ADHD, contributing to the growth of the market.
- Eli Lilly: $22.48 billion in sales revenue
- Johnson & Johnson: $82.58 billion in sales revenue
- Novartis: $47.45 billion in sales revenue
Request Sample Report
Market Segmentation
By Application
◍ Pediatric
◍ Adolescent
◍ Adults
By Product
◍ Stimulants
◍ Non-Stimulants
Request Sample Report
$ X Billion USD
Market Growth
Request Sample Report
THANK YOU Email : sales@reportprime.com USA : +1 507 500 7209 Website : https://www.reportprime.com/ Request Sample Report Contact US Our Clients